Rchr
J-GLOBAL ID：200901036111378765
Update date: Aug. 28, 2020
Takashi Fujimoto
フジモト タカシ | Takashi Fujimoto
Contact this researcher
You can send email directly to the researcher.
MISC (8)：
M Iwasaki, A Nishikawa, N Akutagawa, T Fujimoto, M Teramoto, Y Sakaguchi, H Kato, M Ito, K Yoshida, R Kudo. ElAF/PEA3 reduces the invasiveness of SiHa cervical cancer cells by activating serine proteinase inhibitor squamous cell carcinoma antigen. EXPERIMENTAL CELL RESEARCH. 2004. 299. 2. 525-532
T Fujimoto, A Nishikawa, M Iwasaki, N Akutagawa, M Teramoto, R Kudo. Gene expression profiling in two morphologically different uterine cervical carcinoma cell lines derived from a single donor using a human cancer cDNA array. GYNECOLOGIC ONCOLOGY. 2004. 93. 2. 446-453
Neoadjuvant chemotherapy with cisplatin, aclacinomycin A, and mitomycin C for cervical adenocarcinoma--a preliminary study. Int J Gynecol Cancer. 2004. 14. 483-90
Masahiro Iwasaki, Akira Nishikawa, Noriyuki Akutagawa, Takashi Fujimoto, Mizue Teramoto, Ryuichi Kudo. A case of ovarian actinomycosis. Infectious Disease in Obstetrics and Gynecology. 2003. 11. 3. 171-173
M Iwasaki, A Nishikawa, T Fujimoto, N Akutagawa, K Manase, T Endo, K Yoshida, R Maekawa, T Yoshioka, R Kudo. Anti-invasive effect of MMI-166, a new selective matrix metalloproteinase inhibitor, in cervical carcinoma cell lines. GYNECOLOGIC ONCOLOGY. 2002. 85. 1. 103-107
ｍore...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
